About Us 2019-08-27T16:08:40+00:00

ABOUT US

The Center for Genomic Interpretation (CGI) is an independent 501(c)(3) nonprofit organization founded in 2017. CGI was formed and is overseen by clinical genetic and genomic industry leaders who are passionate about ensuring that patients receive accurate results from their genetic and genomic testing. Therefore, CGI’s nonprofit mission is to drive quality in clinical genetics, genomics and Precision Medicine. CGI works towards the goal of ensuring that all patients get accurate and clinically valid results from their testing. CGI provides quality driving initiatives and services to laboratories, health insurance companies, health systems, employer groups, policy makers, regulators, investors, clinicians, patients and the media to accomplish its life saving mission.

CGI Leadership

JULIE M. EGGINGTON, M.S. Ph.D.

CO-FOUNDER AND CEO

Dr. Eggington has directed clinical genetics programs at Myriad Genetics, Courtagen Life Sciences, & 23andMe prior to co-founding a genetic diagnostics consultancy company in 2016. The need for a disruptive nonprofit organization became clear through this consulting work, and Dr. Eggington co-founded the Center for Genomic Interpretation in 2017. Dr. Eggington serves as CGI’s CEO, and is a member of CGI’s Board of Directors.

Dr. Eggington received her Ph.D. in Biochemistry from the University of Wisconsin-Madison, her M.S. from the University of Utah, and her B.S. with Honors from Brigham Young University. She grew up in the Outback of Australia.

ELAINE LYON, Ph.D., FACMG

VP OF CLINICAL AFFAIRS

Dr. Lyon serves as CGI’s Vice President of Clinical Affairs. Dr. Lyon is an ABMGG Board Certified Medical Director, and is also the director of the Clinical Services Laboratory at HudsonAlpha Institute for Biotechnology. Dr. Lyon was previously a professor of pathology at the University of Utah School of Medicine and a Director at ARUP. She professionally trained at the Universities of Alabama and Utah. Dr. Lyon’s expertise include quality assurance and review

of technical assays.

Dr. Lyon focuses her interest in combining sequence variants with symptoms, family history, and other evidences to determine clinical significance. She coauthored the 2015 ACMG/AMP/CAP Standards and Guidelines for the Interpretation of Sequence Variants currently used across the world. In 2014, she was the president of the international Association for Molecular Pathology (AMP). Dr. Lyon currently serves on boards and committees in the AMP and ACMG organizations.

HEBER SHEFFIELD

STRATEGY DIRECTOR

Mr. Sheffield has been a strategic advisor to CGI from its inception. He currently serves as a member of CGI’s Board of Directors. Mr. Sheffield continues to provide advisory services to domestic and international organizations. He has served on the board of directors and advisory boards of companies headquartered in Tokyo, San Francisco and Salt Lake City. His innovative executive leadership has focused on strategy, governance, and global operations.

He has served in various capacities including Chief Executive Officer and Chief Financial Officer. He began his career practicing as a CPA with PricewaterhouseCoopers.

J. Phil Harrop, PhD, MS, MBA, MHA, FACHE

HEALTHCARE EXECUTIVE AND CGI DIRECTOR

Phil is a CGI Board of Director member. He is a healthcare executive with experience ranging from academic medical centers to rural critical access hospitals. He currently serves as President/Chief Operating Officer of MercyOne West Des Moines Medical Center and Vice President of MercyOne Des Moines Medical Center. MercyOne is a joint operating agreement between CommonSpirit Health and Trinity

Health, two of the largest Catholic healthcare organizations in the United States. He has held multiple previous healthcare leadership roles including Chief Executive Officer, Executive Director and Director.

Phil earned a bachelor of science in business management—finance from Brigham Young University and four degrees from The Ohio State University: a Master of Health Administration, a Master of Business Administration, a Master of Science in public health, and a PhD in health services management and policy. He is a Fellow of the American College of Healthcare Executives (ACHE) and has been elected and appointed to various leadership capacities within ACHE. He has served on numerous boards of directors throughout his career. Harrop has published articles on a variety of healthcare topics and has lectured on healthcare and leadership in several universities across the country.

ADVISORY BOARD

KARL V. VOELKERDING, MD, FCAP

DIRECTOR, MOLECULAR PATHOLOGY FELLOWSHIP & MEDICAL DIRECTOR, GENOMICS AND BIOINFORMATICS

Dr. Voelkerding is a professor of pathology at the University of Utah School of Medicine and a Director at ARUP. He is the former chair of the College of American Pathologists’ Next-Generation Sequencing Project Team, which has developed laboratory accreditation requirements and proficiency testing programs for clinical next-generation sequencing. Dr. Voelkerding is currently chair of the newly formed College of American

Pathologists’ Genomic Medicine Resource Committee. Dr. Voelkerding received his MD from the University of Cincinnati College of Medicine and is board certified in clinical pathology and molecular genetic pathology. His applied research focuses on the translation of genomics technologies into clinical diagnostics. Dr. Voelkerding was the president of the international Association for Molecular Pathology (AMP) in 2001.

ROBERT BURTON, M.S. Ph.D. P.M.P.

HEALTH AND SCIENCE PROGRAM MANAGER AT ANCESTRY
(CGI CO-FOUNDER)

Dr. Burton is currently the Health and Science Program Manager at Ancestry. He was CGI’s co-founder with Dr. Eggington. Dr. Burton served as CGI’s President from 2017 until 2019. He has managed external and internal research and development and productization efforts and delivered complex technical projects in clinical diagnostics, genomics database development, and other cross-functional projects for

23andMe, The Bill and Melinda Gates Foundation, The Cancer Genome Atlas (TCGA), and the Defense Advanced Research Projects Agency (DARPA).

ERICA RAMOS, M.S., LCGC

DIRECTOR AND HEAD OF CLINICAL & BUSINESS DEVELOPMENT AT GEISINGER, AND PAST PRESIDENT FOR THE NATIONAL SOCIETY OF GENETIC COUNSELORS (2018)

Erica Ramos is the Director and Head of Clinical and Business Development at Geisinger. Erica was formerly the Associate Director for Illumina’s “Precision Health & Screening” team. Prior to Illumina, Erica spent 11 years in patient care. Erica was the 2018 President for the National Society of Genetic Counselors, the leading professional organization for genetic counselors with almost 4,000 members.

STEPHANIE BYWATER, CHC, CHP, CIA

CHIEF COMPLIANCE OFFICER AT NEOGENOMICS LABORATORIES

Stephanie has over 13 years’ experience developing and overseeing programs to ensure compliance with various global, federal, and state laws and regulations in the healthcare and biotech industries and is currently the Chief Compliance Officer for NeoGenomics Laboratories, where she sets the strategy for and oversees the organization’s compliance

programs.

Before joining NeoGenomics, she managed global compliance operations for and was the Compliance Officer of the Americas Region at Varian Medical Systems Inc. from 2015 to 2017, with a focus on global anti-corruption and ethical compliance requirements.  Prior to Varian, she was the Compliance and Privacy Officer for Myriad Genetic Laboratories, where she implemented and provided oversight for programs supporting compliance with the Anti-kickback Statute, Stark Law, the Food and Drug Administration, billing and reimbursement, research, and global data privacy and protection requirements from 2010 to 2015.  Stephanie has also provided oversight for corporate compliance programs and internal audit activities for Intermountain Healthcare, IASIS Healthcare, and served as the Information Security Officer for multiple behavioral health and acute care facilities within the Alexian Brothers Health System in Illinois. She has a Bachelor of Science in Healthcare Administration from Northern Illinois University and is a Certified Healthcare Professional (CHP), Certified in Healthcare Privacy (CHP), and a Certified Internal Auditor (CIA).

MATT DAVIES

PRESIDENT AND CEO AT ECHO CONNECTION FOUNDATION & CREATOR OF THE GIVING PRINCIPLES

Matt Davies is a Big Data industry veteran having started using the technologies in production systems before mainstream adoption. He co-founded the Utah Hadoop Users Group and speaks regularly at seminars and training sessions. He works on massive data sets, one of which included tracking data from over 550,000 websites. He has designed and deployed

scalable, flexible, and fault tolerant solutions at Intermountain Medical Center, VA Health, Simplot, Nike, Neiman Marcus, and two of the big four accounting firms. Matt works with the demands of sensitive health care and financial data in the cloud and on premise using Cloudera, Hadoop, and cloud native solutions.

ANDREA BARNES

PRESIDENT AND CEO AT ECHO CONNECTION FOUNDATION & CREATOR OF THE GIVING PRINCIPLES

Andrea Barnes focuses on the charitable sector connecting people who perform humanitarian, artistic, educational, and social services work with people who care. She works with local, national and international donors and has experience implementing large scale technology solutions to manage international charitable operations while ensuring that all charitable laws and regulations are followed.

JOIN THE TEAM